This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| 1 minute read

Based on Consent Via a Privacy Policy, Court Dismissed Privacy Class Action Against Tech Giants Over Health Data Tracking—But Allows Opportunity to Amend

Judge Araceli Martínez-Olguín, in the Northern District of California, dismissed a privacy class action against two major technology companies, which alleged unauthorized interception and sharing of sensitive health data collected via tracking technologies on a telehealth website. The court found that the plaintiffs failed to sufficiently allege a lack of consent to the data practices at issue, but granted leave to amend the complaint.

The plaintiffs, representing putative classes in California, Pennsylvania, and Maryland, claimed that their personal health information—including details about erectile dysfunction prescriptions—was intercepted and shared with the defendants through tracking tools such as the Facebook Pixel and Google Analytics on the telehealth website. The complaint asserted violations of state wiretapping and privacy statutes, as well as constitutional privacy rights.

  • Consent as a Central Defense: Consent generally defeats privacy claims under the relevant statutes. Defendants argued that users consented to data collection and sharing through the website’s Terms & Conditions and Privacy Policy, which users had to accept to access services.

 

  • Ambiguity in Privacy Policies: Earlier versions of the website Privacy Policy were found to be ambiguous and did not explicitly notify users that their sensitive health information would be shared with third parties for advertising purposes. As such, the court determined that these policies did not establish the level of consent necessary to defeat the plaintiffs’ claims for the period before August 2024.

 

  • Change in Policy and Timing: In August 2024, the business updated its Privacy Policy to clearly disclose the use of Meta Pixel and Google Analytics for tracking and sharing personal and health information with third parties, including for advertising. Plaintiffs conceded that this updated policy established user consent for data practices going forward.

 

  • Insufficient Allegations for Pre-Consent Period: The court found that the plaintiffs did not adequately allege that the challenged data sharing practices occurred before the August 2024 policy change, nor did they provide sufficient factual support for claims covering the earlier period.

M.D. v. Google LLC, No. 24-CV-06369-AMO, 2025 WL 2710095 (N.D. Cal. Sept. 23, 2025).

Tags

cipa, cipa 632, cipa section 631
chevron-up